Begin a Phase 1a/1b clinical trial of AB-836 in healthy volunteers and subjects with HBV
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 4 Mar 2021
- Due
- 30 Jun 2021
- Delivered
- Q1 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“AB-836 ... on track to begin a Phase 1a/1b clinical trial in healthy volunteers and subjects with HBV in the first half of 2021”
What we found
Evidence strength A What the grades mean
A later 10-Q reports the AB-836 Phase 1a/1b trial was initiated in Q1 2021, within the first-half-2021 deadline.
-
A Arbutus Biopharma Corp 10-Q filed 2021-08-05
“initiated a Phase 1a/1b clinical trial for AB-836 in the first quarter of 2021 with initial data from healthy volunteers and HBV subjects expected in the second half of 2021” ✓ confirmed on the page
-
A Arbutus Biopharma Corp 10-Q filed 2021-11-04
“initiated a double-blind, randomized, placebo-controlled, single and multiple dose Phase 1a/1b clinical trial evaluating the safety, tolerability, and pharmacokinetics and pharmacodynamics of AB-836 in the first quarter of 2021” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Begin
- Deliverable
- AB-836 Phase 1a/1b clinical trial
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Arbutus Biopharma Corp? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ABUS-025114 · Corrections policy